About Mitra Biotech
Mitra Biotech is a company based in Woburn (United States) founded in 2010 by Mallik Sundaram. Mitra Biotech has raised $40.7 million across 3 funding rounds from investors including Tata Capital, Accel and RA Capital. The company has 1 employees as of March 28, 2024. Mitra Biotech operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Woburn, United States
- Employees 1 as on 28 Mar, 2024
- Founders Mallik Sundaram
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mitra Biotech Private Limited
- Date of Incorporation 18 Dec, 2009
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$158.78 K (USD)-40.66as on Mar 31, 2015
-
Net Profit
-$751.22 K (USD)17.96as on Mar 31, 2015
-
EBITDA
-$824.23 K (USD)16.24as on Mar 31, 2015
-
Total Equity Funding
$40.7 M (USD)
in 3 rounds
-
Latest Funding Round
$27.4 M (USD), Series B
Aug 28, 2016
-
Investors
Tata Capital
& 7 more
-
Employee Count
1
as on Mar 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Mitra Biotech
Unlock access to complete
Funding Insights of Mitra Biotech
Mitra Biotech has successfully raised a total of $40.7M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $27.4 million completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mitra Biotech
Mitra Biotech has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Tata Capital, Accel and RA Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Locked | Locked | Locked | |
|
Accel is recognized as a leading venture capital firm.
|
Locked | Locked | Locked |
Investor details for Mitra Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mitra Biotech
Investment portfolio details for Mitra Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mitra Biotech
Detailed financials for Mitra Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mitra Biotech Comparisons
Peer comparison for Mitra Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mitra Biotech
Mitra Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
Detailed competitors of Mitra Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mitra Biotech
Complete news archive for Mitra Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mitra Biotech
Mitra Biotech was founded in 2010.
Mitra Biotech is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Mitra Biotech is a funded company, having raised a total of $40.7M across 3 funding rounds to date.
As of Mar 28, 2024, the latest employee count at Mitra Biotech is 1.
Annual revenue of Mitra Biotech is $158.78K as on Mar 31, 2015.
Biotechnology company focused on advancing personalized cancer treatment through its clinically validated oncology drug efficacy platform, CANscript.
Mitra Biotech's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Mitra Biotech has 8 investors. Key investors include Tata Capital, Accel, RA Capital, KITVEN, and India Innovation Fund.